About Sharps Technology, Inc.
https://sharpstechnology.comSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
CEO
Robert M. Hayes
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
WALLEYE CAPITAL LLC
Shares:1.05M
Value:$35.96K
EMPERY ASSET MANAGEMENT, LP
Shares:829.85K
Value:$28.55K
CLEAR STREET LLC
Shares:597.68K
Value:$20.56K
Summary
Showing Top 3 of 11
About Sharps Technology, Inc.
https://sharpstechnology.comSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.29M ▲ | $111.54M ▲ | $-105.33M ▼ | -4.6K% ▼ | $-4.33 ▼ | $-105.19M ▼ |
| Q2-2025 | $222.72K ▲ | $1.83M ▼ | $3.56M ▲ | 1.6K% ▲ | $3.58 ▼ | $3.7M ▲ |
| Q1-2025 | $0 | $1.89M ▲ | $1.93M ▲ | 0% | $38.62 ▲ | $2.69M ▲ |
| Q4-2024 | $0 | $1.89M ▲ | $-4.53M ▼ | 0% | $-1.2K ▼ | $-4.37M ▼ |
| Q3-2024 | $0 | $1.82M | $-1.69M | 0% | $-48.94 | $-1.49M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $25.72M ▲ | $443.96M ▲ | $10.75M ▲ | $433.21M ▲ |
| Q2-2025 | $8.32M ▼ | $17.09M ▼ | $2.55M ▼ | $14.54M ▲ |
| Q1-2025 | $11.89M ▲ | $18.92M ▲ | $8.78M ▲ | $10.14M ▲ |
| Q4-2024 | $864.04K ▼ | $7.31M ▼ | $5.32M ▲ | $2M ▼ |
| Q3-2024 | $2.47M | $11.25M | $4.75M | $6.51M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $3.56M ▲ | $-1.91M ▲ | $-1.49M ▼ | $0 ▼ | $-3.57M ▼ | $-3.77M ▼ |
| Q1-2025 | $1.93M ▲ | $-2.45M ▼ | $-473.66K ▼ | $13.95M ▲ | $11.03M ▲ | $-2.54M ▼ |
| Q4-2024 | $-4.53M ▼ | $-1.76M ▼ | $-93.48K ▼ | $199.46K ▼ | $-1.61M ▼ | $-1.83M ▼ |
| Q3-2024 | $-1.69M ▲ | $-1.64M ▼ | $-50.3K ▲ | $2.74M ▼ | $989.9K ▲ | $-1.69M ▼ |
| Q2-2024 | $-2.1M | $-1.64M | $-1.02M | $2.97M | $317.38K | $-1.66M |
CEO
Robert M. Hayes
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B-
Price Target
Institutional Ownership
WALLEYE CAPITAL LLC
Shares:1.05M
Value:$35.96K
EMPERY ASSET MANAGEMENT, LP
Shares:829.85K
Value:$28.55K
CLEAR STREET LLC
Shares:597.68K
Value:$20.56K
Summary
Showing Top 3 of 11